Tender notice observed
Latest variant observed by Bidwake on .
Open this official Find a Tender notice
Record references
- Release reference
054675-2025- Published tags
- tender
Loading records…
Public procurement
See the published facts, notice history, awards and supplier links in one place. Open the original Find a Tender notice for the full record.
ocds-h6vhtk-0595ddPublished facts
003869-2026NHS Arden and Greater East Midlands Commissioning Support Unit (AGCSU), on behalf of NHS England (referred to as the Commissioner), invited suitably qualified and experienced providers to respond to a Competitive Process for the provision of Tumour Infiltrating Lymphocyte (TIL) Therapy hubs for Melanoma (Adults). <br/><br/>Lifileucel is a first in class autologous tumour infiltrating lymphocyte (TIL) cell therapy. This infusion is followed by a short course of interleukin-2 (IL-2). IL-2 is a potent drug and has the potential to cause significant side effects. As such, it is recommended that patients receive treatment at a trust with immediate access to an Intensive Therapy<br/>Unit (ITU).<br/><br/>Lifileucel is being assessed via NICE’s technology appraisal programme for previously treated unresectable or metastatic melanoma in adults, with an expected final guidance publication date in 2026 in line with NICE guidance: https://www.nice.org.uk/guidance/indevelopment/gid-ta10752<br/><br/>The treatment is complex to administer, requiring surgical expertise for tumour<br/>resection, melanoma expertise for patient selection and management post-treatment and cell therapy expertise to administer the cell therapy and manage the side effects and associated care of both Lifileucel and IL-2 administration.<br/><br/>The key objective of the Procurement was to commission Tumour Infiltrating Lymphocyte (TIL)Therapy Hubs for adult patients across the following seven (7) geographical regions to serve the population of England:<br/>Lot 1: London<br/>Lot 2: East of England<br/>Lot 3: South East<br/>Lot 4: South West<br/>Lot 5: Midlands<br/>Lot 6: North East and Yorkshire<br/>Lot 7: North West<br/><br/>This process was designed to enable any provider meeting the required standards to be awarded a contract, with no restriction on the number of sites commissioned.<br/><br/>As a result of this procurement exercise the commissioner intends to award 12 separate contracts across the 7 Lots.<br/><br/>The service is due to commence on 1st May 2025, subject to NICE guidance, for a period of 5 years with the Commissioners having the option to extend for up to an additional 4 year(s)(maximum contract duration 9 years).
Observed notice trail
Events follow the publisher date where one is available. “Seen by Bidwake” is the date this service first found the record.
Tender notice observed
Latest variant observed by Bidwake on .
Open this official Find a Tender notice
054675-2025Award notice observed
Latest variant observed by Bidwake on .
Open this official Find a Tender notice
003869-2026Awards and suppliers
Buyer: NHS EnglandSupplier: UNIVERSITY COLLEGE LONDON HOSPITALS NHS FOUNDATION TRUST
003869-2026-1Buyer: NHS EnglandSupplier: THE NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST
End dates, recurrence wording and links are shown as they appear in public notices. They do not create a new opportunity. If no later linked record appears here, that means Bidwake did not find one in the records it has loaded; it does not prove that none exists.
003869-2026-10Buyer: NHS EnglandSupplier: THE CHRISTIE NHS FOUNDATION TRUST
003869-2026-11Buyer: NHS EnglandSupplier: THE CLATTERBRIDGE CANCER CENTRE NHS FOUNDATION TRUST
003869-2026-12Buyer: NHS EnglandSupplier: Guy's and St Thomas' NHS Foundation Trust
003869-2026-2Buyer: NHS EnglandSupplier: Barts Health NHS Trust
003869-2026-3Buyer: NHS EnglandSupplier: The Royal Marsden NHS Foundation Trust
003869-2026-4Buyer: NHS EnglandSupplier: CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
003869-2026-5Buyer: NHS EnglandSupplier: Oxford University Hospitals NHS FT
003869-2026-6Buyer: NHS EnglandSupplier: University Hospitals Southampton
003869-2026-7Buyer: NHS EnglandSupplier: University Hospitals Bristol and Weston NHS Foundation Trust
003869-2026-8Buyer: NHS EnglandSupplier: UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST
003869-2026-9Following the initial 5 year contract period, the Commissioners has the the option to extend for up to an additional 4 year(s).
Published 16 Jan 2026.Open supporting notice 003869-2026Following the initial 5 year contract period, the Commissioners has the the option to extend for up to an additional 4 year(s).
Published 16 Jan 2026.Open supporting notice 003869-2026No exact source-published process relationship was found.